Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients
Objective: To assess the safety and efficacy of the Genous™ endothelial progenitor cell (EPC) capturing stent in conjunction with HmG-CoA-reductase inhibitors (statins) to stimulate EPC recruitment, in the treatment of patients with de novo coronary artery lesions. Methods and results: The HEALING I...
Main Authors: | den Dekker, W, Houtgraaf, J, Onuma, Y, Benit, E, de Winter, R, Wijns, W, Grisold, M, Verheye, S, Silber, S, Teiger, E, Rowland, S, Ligtenberg, E, Hill, J, Wiemer, M, den Heijer, P, Rensing, B, Channon, K, Serruys, P, Duckers, H |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
2011
|
Títulos similares
-
Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients.
por: den Dekker, W, et al.
Publicado: (2011) -
EFFICACY AND SAFETY OF GLYCOPROTEIN IIB/IIIA BLOCKER MONOFRAM IN CORONARY STENTING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
por: E. I. Makhiyanova, et al.
Publicado: (2016-01-01) -
Everolimus-Eluting Biodegradable Abluminal Coating Stent versus Durable Conformal Coating Stent: Termination of the Inflammatory Response Associated with Neointimal Healing in a Porcine Coronary Model
por: Masayuki Mori, et al.
Publicado: (2020-01-01) -
Comparison of the Absorbable Polymer Sirolimus-Eluting Stent (MiStent) to the Durable Polymer Everolimus-Eluting Stent (Xience) (from the DESSOLVE I/II and ISAR-TEST-4 Studies)
por: Lansky, Alexandra J., et al.
Publicado: (2018) -
Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial.
por: Tanabe, K, et al.
Publicado: (2005)